Researchers have developed a new approach to characterizing and monitoring changes in cellular structure. The new type of single-cell-based assay, developed by researchers at Roswell Park Cancer Institute (RPCI) and the University ...
Oct 20, 2014
0
0
(Medical Xpress)—A new test developed by researchers from the University of Manchester could revolutionise the discovery of new prescription drugs. The test will help determine which drugs are unlikely to work at an early ...
Oct 2, 2014
0
0
(Medical Xpress)—Before joining Washington University in St. Louis, Michael Kinch, PhD, was managing director of the Center for Molecular Discovery at Yale University. "A few years ago, to motivate the team I gave them ...
Sep 23, 2014
0
1
The breast cancer drug trastuzumab emtansine (also known as Kadcyla) will not be made routinely available on the NHS following a failure to reach an agreement on price between the National Institute for Health and Care Excellence ...
Aug 11, 2014
0
0
Japanese prosecutors Tuesday laid charges against the local unit of Swiss pharmaceutical giant Novartis in a widening scandal over claims that falsified data were used to exaggerate the benefits of a popular blood-pressure ...
Jul 1, 2014
0
0
Why are e-cigarettes so popular among Americans who want to quit smoking, even though so little is known about their safety or effectiveness? The answer lies in their marketing – they are simply "cooler" than nicotine inhalers. ...
Jun 3, 2014
0
0
(HealthDay)—The U.S. Food and Drug Administration on Friday gave its approval to the first generic version of the pain reliever Celebrex (celecoxib).
Jun 3, 2014
0
0
(Medical Xpress)—Yale's Michael Kinch spent his spare time in the last year creating a massive database that encompasses the entire history of drug development in the United States. In a series of 20 articles scheduled ...
Apr 30, 2014
0
0
Cost-effectiveness is paramount for any new medical technology. If pharmaceutical companies do not see a profit, new drugs will never see the light of day. And if insurance companies think a new treatment is more expensive ...
Mar 26, 2014
0
0
Patients with advanced non-small cell lung cancer (NSCLC) often suffer the challenging side effects of drug regimens that may not have any impact, says Jayson Parker, PhD, a lecturer at U of T Mississauga. Meanwhile pharmaceutical ...
Feb 25, 2014
0
0
